Choosing a study population for the evaluation of antifungal prophylaxis

Clin Infect Dis. 2005 Jun 1;40(11):1699; author reply 1699-701. doi: 10.1086/429823.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antifungal Agents / therapeutic use*
  • Echinocandins
  • Fluconazole / therapeutic use
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Humans
  • Lipopeptides
  • Lipoproteins / therapeutic use
  • Micafungin
  • Mycoses / etiology
  • Mycoses / prevention & control*
  • Patient Selection*
  • Peptides, Cyclic / therapeutic use

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Lipoproteins
  • Peptides, Cyclic
  • Fluconazole
  • Micafungin